Putnam Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$508K Buy
36,520
+10,420
+40% +$139K ﹤0.01% 932
2023
Q3
$349K Buy
26,100
+1,625
+7% +$22K ﹤0.01% 1021
2023
Q2
$309K Hold
24,475
﹤0.01% 1079
2023
Q1
$279K Buy
+24,475
New +$264K ﹤0.01% 1090

Other funds holding RDY

Putnam Investments's RDY Position: Q4 2023 in Review

Putnam Investments increased its Dr. Reddy's Laboratories (RDY) stake by 40% in Q4 2023, buying an estimated $139K and bringing the position to 36,520 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

Putnam Investments first reported a position in RDY in Q1 2023 and has held it in 4 quarters since. 224 funds tracked by Wall St. Rank hold RDY as of Q4 2023.

  • Putnam Investments held 36,520 shares of Dr. Reddy's Laboratories worth $508K as of Q4 2023.
  • Putnam Investments bought 10,420 Dr. Reddy's Laboratories shares in Q4 2023, an estimated $139K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #932 holding.
  • Putnam Investments first reported a position in Dr. Reddy's Laboratories in Q1 2023 and has held it in 4 quarters since.
  • 224 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.